Management of Chronically Colonized JJ Stents
Introduction to Colonization and Infection
- The American College of Radiology recommends that bacteriuria in asymptomatic patients with a JJ stent should not be treated, as it reflects colonization of the device rather than a true infection, and treating asymptomatic bacteriuria promotes the emergence of multidrug-resistant bacteria 1
- The colonization of a JJ stent occurs rapidly after placement, with the formation of a complex intraluminal biofilm over time, according to the Ca-A Cancer Journal for Clinicians 2, 1
Diagnosis and Treatment of Infections
- The Journal of the American College of Radiology suggests that only symptomatic infections should be treated, with symptoms including fever 3, 4, flank pain 3, leukocytosis 3, and signs of sepsis (hypotension, tachycardia) 3, 4
- The Ca-A Cancer Journal for Clinicians recommends a targeted prophylactic approach based on the growth of colonizing organisms in a urine culture obtained a few days before a scheduled exchange, which seems to have a more protective effect than standard prophylactic antimicrobials 2, 1
Long-Term Management Strategies
- The Ca-A Cancer Journal for Clinicians suggests that routine replacement of the device every 3 months or even more frequently in high-risk patients for intraluminal obstruction should be attempted, and definitive removal should be performed when clinically possible 2, 1, 5, 4
- The cost of routine replacement is justified, as it is significantly lower than the cost of treatment for each episode of infectious events, with a mean cost of $3,000 per procedure compared to $40,000 for treatment 2, 1, 5
Clinical Surveillance
- The Ca-A Cancer Journal for Clinicians recommends focusing on clinical symptoms rather than culture results 1, 6
- The Journal of the American College of Radiology suggests monitoring renal function (creatinine, urea) to detect obstruction and periodic imaging (ultrasound) to evaluate hydronephrosis, although specific citations for these points are not provided in the original text, the overall strategy for surveillance is supported by 2, 1
Management of Stent Colonization and Criteria for Restarting Antibiotics
Indications for Re‑initiating Antibiotic Therapy
- Empiric antibiotics (e.g., ceftriaxone 1–2 g daily or piperacillin‑tazobactam 3.375–4.5 g three times daily) should be restarted immediately when any of the following clinical signs appear: fever ≥ 38.3 °C, new or worsening flank pain, hemodynamic instability (hypotension or tachycardia), rising serum creatinine suggesting obstruction, or any other evidence of clinical deterioration. 7
Impact of Immunosuppression on Infection Risk
- Recent chemotherapy‑induced immunosuppression markedly increases the risk that ureteral stent colonization will progress to a true infection, necessitating closer clinical surveillance even in the absence of symptoms. 7
Stent Management in Malignancy‑Related Obstructive Uropathy
- When a ureteral stent is required for obstructive uropathy secondary to pelvic malignancy, definitive stent removal should be deferred until the underlying cancer is adequately controlled; management should focus on symptom‑based monitoring and scheduled stent exchanges (e.g., every three months). 8